Ashwagandha For Sexual Function Research

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

RD

By Gabriela Mitchell, Registered Dietitian (Linkedin)

Last Updated July 2026  ·  26 min read

10% off · weekly tips

Real science on cortisol, stress, and sleep.

Send it →

A comprehensive review of clinical trials, study data, and what the research means for real people

---

Table of Contents

• What Is Ashwagandha and Why Are Researchers Studying It for Sexual Health?
• The Active Compounds: How Withanolides May Influence Sexual Function
• Ashwagandha and Male Sexual Function: What the Studies Show
• Ashwagandha and Testosterone: The Hormonal Connection
• Ashwagandha for Female Sexual Function: Emerging Clinical Evidence
• The FSFI Data: Measuring Female Sexual Outcomes in Trials
• Does Ashwagandha Help With Erectile Dysfunction?
• Root Extract vs. Powder: Does Form Matter for Sexual Benefits?
• KSM-66: The Most Studied Ashwagandha Formulation for Sexual Health
• Dosing, Safety, and Side Effects Based on Clinical Research
• Frequently Asked Questions
• The Bottom Line: What the Research Tells Us in 2026

---

What Is Ashwagandha and Why Are Researchers Studying It for Sexual Health?

Ashwagandha (Withania somnifera) has occupied a central position in Ayurvedic medicine for more than 3,000 years. Classified as a rasayana — a rejuvenating herb meant to promote vitality, longevity, and reproductive wellness — it was traditionally prescribed for conditions modern medicine would recognize as low libido, sexual fatigue, and male infertility. But it is only in the last decade, and particularly between 2013 and 2026, that rigorous placebo-controlled trials have begun testing these traditional claims against modern clinical standards.

The reason for growing scientific interest is multifactorial. Sexual dysfunction is pervasive: estimates suggest roughly 40–45% of women and 20–30% of men experience some form of sexual health complaint at some point in their adult lives. Pharmaceutical options exist — phosphodiesterase-5 inhibitors for erectile dysfunction, hormonal therapies for desire disorders — but these come with significant side effects, contraindications, and cost barriers. Patients and clinicians alike are seeking well-evidenced complementary options, and ashwagandha has emerged as one of the most promising botanicals under investigation.

What distinguishes ashwagandha from many other herbal supplements is the quality of its research base. Unlike most botanical remedies that exist only in the form of small, poorly controlled pilot studies, ashwagandha now has multiple randomized, double-blind, placebo-controlled trials specifically examining sexual outcomes. These trials use validated psychometric instruments — the International Index of Erectile Function (IIEF), the Female Sexual Function Index (FSFI), the Sexual Desire Inventory (SDI-2) — which makes the data comparable, credible, and clinically meaningful.

This post reviews the full body of available evidence on ashwagandha for sexual function research, covering male and female outcomes, hormonal mechanisms, specific formulations, and what you can and cannot conclude from the current literature.

---

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

The Active Compounds: How Withanolides May Influence Sexual Function

Before examining individual studies, it is worth understanding why ashwagandha might affect sexual function at all. The answer lies primarily in a class of steroidal lactones called withanolides, the bioactive compounds responsible for most of ashwagandha's pharmacological activity. The connection between withanolide libido research and observed clinical outcomes is increasingly well-understood, even if all mechanisms have not been fully elucidated.

Key Proposed Mechanisms

1. Adaptogenic stress reduction via the HPA axis

Ashwagandha's most replicated pharmacological effect is the reduction of cortisol through modulation of the hypothalamic-pituitary-adrenal (HPA) axis. This is directly relevant to sexual function because chronic psychological stress — and the elevated cortisol that accompanies it — is one of the most common suppressors of libido, arousal, and sexual satisfaction in both sexes. Cortisol and testosterone are both derived from pregnenolone (the so-called "pregnenolone steal"), meaning that when the body is under chronic stress, hormonal resources are preferentially allocated to cortisol production at the expense of sex hormone synthesis.

By attenuating cortisol levels, ashwagandha may indirectly restore the hormonal environment necessary for healthy sexual desire and performance.

2. Gonadotropin modulation

Multiple studies in oligospermic males have documented increases in luteinizing hormone (LH) alongside testosterone increases after ashwagandha supplementation. LH is the pituitary signal that triggers testicular testosterone production, suggesting ashwagandha may work at least partly upstream of the gonadal axis rather than directly at the testicular level.

3. Nitric oxide pathway support

Some withanolide compounds appear to support endothelial nitric oxide synthase (eNOS) activity. Nitric oxide is the molecular trigger for penile smooth muscle relaxation and the physiological mechanism underlying erection — it is the same pathway targeted by sildenafil (Viagra). Whether ashwagandha's effects on this pathway are clinically significant for erectile outcomes remains an open question (as the ED-specific data discussed later will show), but it represents a plausible biological mechanism worth continued investigation.

4. Direct androgenic activity

Some researchers have proposed that certain withanolides possess mild androgenic activity themselves, potentially binding to androgen receptors or stimulating steroidogenesis. The steroidal backbone of withanolides is structurally similar to endogenous steroid hormones, which makes this pharmacologically plausible.

5. Antioxidant effects on spermatogenesis

Oxidative stress is a major cause of sperm DNA damage and reduced sperm motility. The withanolide-rich root extract has demonstrated significant antioxidant activity in multiple experimental models, which may partially explain the dramatic improvements in semen parameters documented in clinical trials.

Understanding these mechanisms provides important context for interpreting the clinical data. Ashwagandha is not a direct vasodilator like PDE5 inhibitors — it is a systemic adaptogen whose sexual benefits appear to work through stress reduction, hormonal normalization, and improvements in the physiological substrate of sexual health.

Ashwagandha and Male Sexual Function: What the Studies Show

The clinical evidence for ashwagandha male sexual function improvements has grown substantially in recent years. Two particularly important randomized controlled trials published in 2024–2026 now provide high-quality data on outcomes in healthy adult men.

The 2026 RCT: Healthy Adult Males

The most recent and methodologically rigorous ashwagandha libido study available at the time of writing was an 8-week randomized, double-blind, placebo-controlled trial examining the efficacy and safety of ashwagandha root extract on sexual function in healthy adult males. The results were striking and statistically robust.

Key outcomes (all p ≤ 0.011):

| Outcome Measure | Finding | |----------------|---------| | Sexual desire (SDI-2) | Statistically significant increase | | Spontaneous sexual events (SSEs) | Statistically significant increase | | Overall sexual function (IIEF) | Statistically significant improvement | | Ejaculate volume | 36% increase | | Total sperm count | 38% increase | | Sperm motility | 87% increase |

The p-values at or below 0.011 across all primary endpoints in a double-blind trial are clinically meaningful. These are not marginal trends — they represent effects that would be expected to occur by chance fewer than 11 times in 1,000 repetitions of the same experiment.

Importantly, no adverse events were reported in the ashwagandha group, and tolerability was rated positively by participants throughout the trial.

The 2024–2026 Infertility Center Study

A complementary RCT, also published in the 2024–2026 window, examined outcomes in healthy men attending an infertility center — a population with higher baseline motivation to improve semen and sexual parameters. This 8-week trial confirmed improvements across multiple IIEF domains, specifically:

• Orgasmic function — statistically significant improvement
• Sexual desire — statistically significant improvement
• Overall satisfaction — statistically significant improvement
• SDI-2 score — statistically significant increase

Quality of life as measured by SF-12 also improved significantly (p < 0.05), which is notable because sexual dysfunction has a well-documented negative impact on general wellbeing. Crucially, no adverse events were reported in this study either.

The 2013 Oligospermic Males Study: A Foundational Reference

While older, the 2013 study in oligospermic males remains one of the most cited pieces of evidence in ashwagandha for sexual function research because of the magnitude of its reported effects. Over a 3-month supplementation period, researchers documented:

• 167% increase in sperm concentration (from approximately 9 million to 26 million sperm/mL)
• 53% increase in semen volume
• 57% increase in sperm motility
• 17% increase in serum testosterone
• 34% increase in LH

These are extraordinary numbers. A 167% improvement in sperm concentration in a population with documented oligospermia over just three months represents a clinically significant outcome that would materially improve fertility prospects. The concurrent increases in testosterone and LH suggest the mechanism involves upregulation of the hypothalamic-pituitary-gonadal axis rather than simply a localized testicular effect.

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Ashwagandha and Testosterone: The Hormonal Connection

The relationship between ashwagandha testosterone levels and sexual function outcomes is one of the most investigated aspects of this herb's pharmacology. Testosterone is the primary androgen driving sexual desire in both men and women (yes, testosterone plays a significant role in female libido as well), and its reduction — whether through aging, chronic stress, or primary hypogonadism — is strongly associated with reduced sexual interest, energy, and performance.

What the Evidence Shows

The 2013 oligospermic males study reported a 17% increase in testosterone alongside the dramatic improvements in semen parameters. While 17% may sound modest, it is worth contextualizing: a 17% increase in testosterone from a baseline that is already clinically meaningful can shift a person from the lower end of normal range to the mid-to-upper normal range — a shift that has real, noticeable subjective effects on energy, libido, and mood.

Other studies examining testosterone as a secondary outcome in ashwagandha trials have consistently found either statistically significant increases or positive trends, though the magnitude varies. A meta-analysis published in the American Journal of Men's Health pooled data from multiple controlled trials and found a consistent, statistically significant increase in serum testosterone in supplemented men compared to controls.

The Cortisol-Testosterone Relationship

Perhaps the most clinically elegant explanation for ashwagandha's effect on testosterone involves its well-documented cortisol-lowering properties. When cortisol is chronically elevated, it suppresses gonadotropin-releasing hormone (GnRH) pulsatility, reduces LH secretion, and directly inhibits testicular Leydig cell function. By attenuating the cortisol response, ashwagandha removes one of the most common functional suppressors of testosterone production without requiring any direct androgenic action.

This mechanism is supported by the observation that ashwagandha's testosterone-raising effects tend to be more pronounced in populations under chronic stress — a finding consistent with the cortisol-mediated pathway rather than a direct androgenic mechanism.

Testosterone and Female Sexual Desire

It is worth noting that testosterone's role in female libido is clinically recognized, even though it receives far less attention in popular media. Women with low testosterone (relative to their normal range) often report significantly reduced sexual desire, reduced genital sensitivity, and difficulty achieving arousal or orgasm. The fact that ashwagandha may modestly raise testosterone levels is therefore relevant not only to male sexual outcomes but also to the female sexual function data discussed in the next section.

Ashwagandha for Female Sexual Function: Emerging Clinical Evidence

The data on KSM-66 female sexual function has expanded considerably since the landmark 2015 study and now includes a 2025 prospective, double-blind, placebo-controlled trial that provides some of the most rigorous evidence yet on ashwagandha's effects in women with sexual dysfunction.

The 2025 Female Sexual Dysfunction Trial

The 2025 trial specifically examined the efficacy and safety of ashwagandha root extract on sexual health in healthy women with female sexual dysfunction (FSD). The study design was methodologically strong — prospective, double-blind, placebo-controlled — and the outcomes were consistently positive:

• Significant improvement in overall sexual function in the ashwagandha group vs. placebo
• Significant improvement in quality of life related to sexual health
• Well-tolerated throughout the trial period
• No adverse events reported in either group

This trial adds to a growing body of evidence suggesting that ashwagandha is effective across multiple dimensions of female sexual health, not merely desire but the broader construct of sexual wellbeing that includes satisfaction, emotional connection, and quality of life.

Why Ashwagandha May Benefit Women Specifically

Female sexual dysfunction is a complex, multidimensional condition. The Diagnostic and Statistical Manual identifies several subtypes: hypoactive sexual desire disorder (HSDD), female sexual arousal disorder, genito-pelvic pain/penetration disorder, and orgasmic disorder. The fact that ashwagandha appears to improve outcomes across multiple FSFI domains — as the 2014 trial data shows — suggests it is addressing underlying physiological and psychological substrates rather than a single narrow pathway.

Stress and anxiety are disproportionately implicated in female sexual dysfunction compared to male dysfunction. The adaptogenic, cortisol-lowering effects of ashwagandha are therefore particularly relevant to women, many of whom cite psychological stress as their primary barrier to sexual desire and arousal.

Additionally, the mild testosterone-raising effects discussed above may contribute to improved genital sensitivity and desire in women, consistent with the established role of androgens in female sexual physiology.

The FSFI Data: Measuring Female Sexual Outcomes in Trials

The ashwagandha FSFI connection deserves its own section because the Female Sexual Function Index is the gold-standard validated instrument for measuring female sexual outcomes in clinical research. The FSFI assesses six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. A total FSFI score below 26.55 is the established clinical threshold for female sexual dysfunction.

The 2014 FSFI Trial: Detailed Data

The most detailed ashwagandha arousal study using FSFI as a primary outcome measure was published in 2014 and examined the effects of ashwagandha root extract (specifically the HCARE formulation) in women with sexual dysfunction. The results were statistically powerful:

| FSFI Domain | Finding | |-------------|---------| | FSFI Total Score | Significant increase (p < 0.001) | | Arousal | Significant increase (p < 0.001) | | Lubrication | Significant increase (p < 0.001) |

The p < 0.001 threshold across total score, arousal, and lubrication is exceptionally strong for a botanical supplement trial. These are not borderline findings — they represent effects that would be expected by chance fewer than 1 in 1,000 times.

What FSFI Improvements Mean in Practice

An improvement in the arousal domain of the FSFI corresponds to subjective reports of increased ease of becoming aroused, stronger subjective arousal response, and more frequent spontaneous arousal. An improvement in the lubrication domain corresponds to both subjective and objective genital response — these are not simply psychological shifts but physiological changes in genital blood flow and secretory function.

For many women, particularly those whose dysfunction has persisted through multiple prior interventions, these improvements represent a meaningful restoration of sexual quality of life.

The 2025 Study and FSFI Convergence

While the 2025 trial did not publish granular FSFI domain breakdowns at the time of this writing, its overall finding of "significant improvement in sexual function" in women with FSD is consistent with the 2014 FSFI data and represents a replication of the core finding across different study populations, formulations, and research teams — exactly the kind of convergent evidence that strengthens clinical confidence.

Does Ashwagandha Help With Erectile Dysfunction?

This is perhaps the most important nuance in the entire body of research on ashwagandha sexual dysfunction, and it deserves direct, honest treatment: the current evidence does not support ashwagandha as an effective treatment for erectile dysfunction in men with established ED.

The High-Dose Powder Study

A controlled trial examined ashwagandha in men with erectile dysfunction at a dose of 6,000 mg per day of ashwagandha powder over 2 months. The result was unequivocal: no significant benefit over placebo on erectile function or ejaculatory latency. This was not a small or methodologically weak study — the null finding was robust.

This result is critical context for anyone considering ashwagandha specifically for erection problems.

How to Reconcile the Positive and Negative Data

At first glance, positive data on sexual desire and IIEF scores in healthy men alongside a null finding in men with ED appears contradictory. But it is actually entirely coherent when you consider the different mechanisms at play:

In healthy men, ashwagandha appears to improve desire, spontaneous arousal, and semen parameters — outcomes likely mediated through stress reduction, cortisol low ering, and modest testosterone increases. These are central (brain/hormone-mediated) effects on sexuality, not peripheral (vascular/erectile) effects.

In men with established ED, the primary pathology is often vascular — reduced arterial inflow to the corpora cavernosa, venous leak, or endothelial dysfunction — that requires either a potent vasodilator (like a PDE5 inhibitor) or treatment of the underlying cardiovascular risk factors. Ashwagandha's adaptogenic mechanisms are unlikely to address established vascular pathology.

In other words: ashwagandha appears effective for desire-phase and hormonal components of male sexual health, but does not appear effective for the mechanical, vascular components of erectile dysfunction. These are different physiological problems requiring different interventions.

When to Consider Pharmaceutical Options

If erectile dysfunction is your primary concern and it is consistently present regardless of desire or context, the current evidence strongly favors consulting a physician about PDE5 inhibitors or investigating underlying cardiovascular, hormonal, or psychological causes. Ashwagandha is not a substitute for this evaluation.

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Root Extract vs. Powder: Does Form Matter for Sexual Benefits?

One of the most practically important distinctions in interpreting the research literature — and one that is frequently overlooked in popular coverage — is the difference between ashwagandha root extract and ashwagandha powder.

Why This Distinction Matters

Ashwagandha powder is simply dried, ground root material. It contains withanolides (the active compounds), but at variable and relatively low concentrations — typically 0.5–1.5% withanolides by weight, depending on the source and agricultural conditions.

Ashwagandha root extract, by contrast, is a standardized, concentrated preparation that guarantees a minimum withanolide content — typically 2.5–5% or higher. This standardization ensures that a given dose contains a predictable, clinically meaningful quantity of active compounds.

The Evidence Comparison

The failed high-dose study used 6,000 mg/day of ashwagandha powder and found no benefit for erectile dysfunction. This dose sounds enormous — and it is — but it likely contained approximately 30–90 mg of withanolides total.

The positive trials for male and female sexual function used 300–600 mg/day of standardized root extract, which at 2.5–5% withanolide standardization would deliver approximately 7.5–30 mg of withanolides per dose — a quantity that, despite the lower absolute weight, is delivered in a more bioavailable, consistent form.

This comparison illustrates that more milligrams is not the same as more active ingredient, and that the form of ashwagandha used in a study profoundly affects what conclusions can be drawn.

Practical Implication

When selecting an ashwagandha supplement based on the sexual function research, the evidence supports standardized root extract with a specified withanolide percentage over raw ashwagandha powder. Products that do not specify their withanolide content cannot be assumed to deliver the concentrations used in positive clinical trials.

KSM-66: The Most Studied Ashwagandha Formulation for Sexual Health

KSM-66 sexual health research represents the highest-quality subset of the ashwagandha literature because it uses a single, consistently manufactured, patented root extract with verified withanolide content — making its findings more reproducible and practically applicable than studies using unspecified ashwagandha preparations.

KSM-66 is produced by Ixoreal Biomed and is extracted using a proprietary process that uses only the root (not the leaves, which contain different phytochemical profiles) and maintains a minimum 5% withanolide concentration. It holds GRAS (Generally Recognized as Safe) status in the United States and has been the subject of numerous IRB-approved clinical trials.

KSM-66 in Male Sexual Function Research

Multiple trials using KSM-66 specifically have documented improvements in male sexual outcomes including sperm count, motility, testosterone, and validated desire scores. The KSM-66 female sexual function data from the 2014 HCARE (which uses the KSM-66 root extract base) trial showing p < 0.001 improvements in FSFI total score, arousal, and lubrication is among the most statistically impressive in the field.

Why Standardization Matters for Research Interpretation

The fact that KSM-66 is a standardized extract with a fixed withanolide profile means that positive findings in KSM-66 trials are more likely to be reproducible and more likely to translate to consumer products using the same extract. Generic "ashwagandha" products with unknown withanolide content cannot be assumed to replicate the effects documented in KSM-66 trials.

This is not a commercial endorsement of a single brand but a methodological point about how to interpret research: the formulation used in a study is as important as the dose, duration, and population when evaluating whether findings are applicable to a specific supplement purchase.

Dosing, Safety, and Side Effects Based on Clinical Research

Doses Used in Positive Sexual Function Trials

Based on the available clinical literature, the most consistently used and effective doses in positive trials are:

| Population | Dose | Duration | Formulation | |------------|------|----------|-------------| | Healthy males (desire, semen) | 300–600 mg/day | 8 weeks | Standardized root extract | | Oligospermic males (sperm/testosterone) | 675 mg/day (3 × 225 mg) | 3 months | Root extract | | Women with FSD (FSFI outcomes) | 300 mg twice daily | 8 weeks | Standardized root extract |

Lower doses (300 mg/day) appear effective for many psychological/desire outcomes, while higher doses or longer durations may be needed for semen parameter improvements.

Safety Profile Across Sexual Function Trials

One of the most consistent findings across all the trials reviewed in this article is an excellent safety profile. In every study reporting adverse events:

• No serious adverse events were reported in ashwagandha groups
• Tolerability ratings were consistently positive
• Dropout rates due to side effects were not significantly different from placebo groups

This is a meaningful safety signal: across multiple independent research teams, in both male and female populations, using different formulations and doses, ashwagandha root extract appears safe and well-tolerated for periods up to 3 months.

Known Cautions and Contraindications

Despite the positive safety data in clinical trials, several cautions are worth noting based on broader ashwagandha pharmacology:

Thyroid conditions: Ashwagandha may stimulate thyroid hormone synthesis. People with hyperthyroidism or taking thyroid medication should consult a physician before use.

Autoimmune conditions: The immunomodulating activity of withanolides means ashwagandha could theoretically exacerbate autoimmune conditions or interact with immunosuppressive medications.

Pregnancy: Ashwagandha is traditionally classified as a uterine stimulant in Ayurvedic medicine and has not been adequately studied in pregnant women. It should be avoided during pregnancy.

Sedative interactions: Ashwagandha has mild GABA ergic activity and may potentiate sedative medications (benzodiazepines, barbiturates, certain antihistamines).

Solanaceae allergy: As a member of the nightshade family, individuals with known solanaceae allergies should use caution.

When to Expect Results

Based on the trial data, the onset of benefits varies by outcome type:

• Desire and arousal improvements: Some trials report subjective improvements within 2–4 weeks, consistent with the cortisol-lowering timeline
• FSFI score improvements: Typically measured at 8 weeks in trial protocols, suggesting this is a meaningful minimum evaluation period
• Semen parameter improvements: The most dramatic changes (sperm count, motility) were documented after 8 weeks in the 2026 study and 3 months in the 2013 study — consistent with the spermatogenic cycle, which takes approximately 72–74 days

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Frequently Asked Questions

Does ashwagandha improve erectile dysfunction?

Based on the current evidence, ashwagandha does not appear to improve erectile dysfunction in men with established ED. The most directly relevant trial used 6,000 mg/day of ashwagandha powder for 2 months and found no benefit over placebo on erection quality or ejaculatory latency. The positive male sexual function data from 2024–2026 applies to healthy men without ED — specifically improving sexual desire, spontaneous events, and semen parameters — not to the mechanical, vascular pathology underlying most cases of erectile dysfunction.

If you have consistent erection problems, the appropriate first step is evaluation by a physician for underlying vascular, hormonal, or psychological causes and discussion of evidence-based treatments including PDE5 inhibitors.

How much ashwagandha should I take for libido or sexual performance?

Positive clinical trials for libido and desire used doses of 300–600 mg/day of standardized ashwagandha root extract (typically standardized to 2.5–5% withanolides). This is substantially lower in absolute weight than what some commercial products suggest, but the key variable is withanolide content, not raw milligrams. For semen parameter improvements, 675 mg/day divided into three doses over 3 months has been used effectively.

Always choose a product specifying its withanolide percentage and, where possible, use a formulation consistent with those studied in clinical trials (such as KSM-66).

Can ashwagandha increase testosterone and sperm count?

Yes, based on clinical evidence. The 2013 oligospermic males trial documented a 17% increase in testosterone, a 34% increase in LH, a 167% increase in sperm concentration, and a 57% increase in sperm motility after 3 months of supplementation. The 2026 RCT in healthy adult males documented a 38% increase in total sperm count and an 87% increase in sperm motility after 8 weeks. These are reproducible findings across independent research teams.

The testosterone effect appears mediated primarily through cortisol reduction and upregulation of the hypothalamic-pituitary-gonadal axis rather than direct androgenic activity.

Is ashwagandha effective for women's sexual health?

Yes, the evidence supports this. The 2025 double-blind, placebo-controlled trial in women with female sexual dysfunction found significant improvements in sexual function and quality of life with no adverse events. The 2014 FSFI trial found statistically significant improvements in total FSFI score, arousal, and lubrication (all p < 0.001). Ashwagandha's stress-reducing mechanisms are particularly relevant to women, for whom psychological stress is a primary driver of sexual dysfunction.

Are there side effects from using ashwagandha for sexual function?

Clinical trials consistently report no serious adverse events in ashwagandha groups supplementing at 300–675 mg/day of root extract for 8–12 weeks. Mild gastrointestinal effects (nausea, stomach upset) are occasionally reported, typically at higher doses, and resolve on discontinuation. The safety profile across all reviewed sexual function trials is excellent. Standard cautions apply for specific populations: pregnant women, people with hyperthyroidism, autoimmune conditions, or those taking sedative medications should consult a physician before use.

Does ashwagandha work better than prescribed ED medications?

No. Pharmaceutical PDE5 inhibitors (sildenafil, tadalafil, vardenafil) have robust, large-scale clinical evidence for erectile dysfunction with response rates of 60–80% in appropriate candidates. Ashwagandha has demonstrated no benefit over placebo for erectile dysfunction specifically, while showing meaningful benefits for desire, semen quality, and overall sexual satisfaction in healthy men. These are different outcomes serving different needs — ashwagandha is not a replacement for ED medication.

What's the difference between ashwagandha root extract vs. powder for sexual benefits?

This distinction is critical. Root extract is standardized to a guaranteed withanolide concentration (typically 2.5–5%) and has been used in virtually all positive clinical trials. Ashwagandha powder is unstandardized, variable in withanolide content, and was used in the one high-dose trial that found no benefit for ED at 6,000 mg/day — a dose that actually contained fewer active compounds than a typical 300 mg dose of standardized extract. When purchasing ashwagandha for sexual health purposes, standardized root extract with stated withanolide percentage is strongly preferred based on the research evidence.

The Bottom Line: What the Research Tells Us in 2026

The body of clinical research on ashwagandha for sexual function has matured considerably, and the current evidence — including high-quality randomized controlled trials published in 2024–2026 — supports several specific, evidence-based conclusions.

What Ashwagandha Can Do for Sexual Health

In healthy men:

• Significantly improves sexual desire as measured by SDI-2 (p ≤ 0.011)
• Improves overall sexual function on the IIEF
• Increases spontaneous sexual events
• Improves orgasmic function and satisfaction
• Dramatically improves semen parameters (38% increase in sperm count, 87% increase in motility in the most recent trial)
• Modestly increases testosterone and LH, particularly in oligospermic men

In women with sexual dysfunction:

• Significantly improves FSFI total score and specific domains including arousal and lubrication (p < 0.001)
• Improves overall sexual function and quality of life in double-blind controlled trials
• Addresses desire and arousal dimensions of FSD with a favorable safety profile

What Ashwagandha Cannot Do

• It does not treat erectile dysfunction — the specific vascular/mechanical pathology underlying established ED does not respond to ashwagandha based on controlled trial evidence
• It is not a substitute for PDE5 inhibitors or other evidence-based ED treatments

The Formulation Imperative

The research strongly favors standardized root extract (particularly KSM-66 or equivalent, verified 2.5–5% withanolides) over raw ashwagandha powder. Dose matters, but withanolide content matters more. Most positive sexual function trials used 300–675 mg/day of standardized extract — significantly less in absolute weight than some commercial products suggest, but far more potent in active compound delivery.

Looking Forward

The 2024–2026 publications represent a significant step forward in the rigor and specificity of ashwagandha sexual function research. With multiple independent teams now replicating positive findings in both male and female populations using validated psychometric instruments, the evidence base has crossed the threshold from "promising preliminary data" to "clinically credible evidence." Future research directions that would further strengthen the field include dose-response studies, longer-duration trials (beyond 3 months), trials in older populations, and mechanistic studies using biomarkers of the proposed cortisol-testosterone-nitric oxide pathways.

For now, ashwagandha root extract stands as one of the most evidence-supported botanical interventions for sexual desire, semen quality, and female sexual function currently available — with a safety profile that clinical trial data consistently describes as excellent.

This article is for educational purposes and does not constitute medical advice. Sexual dysfunction can have underlying physiological and psychological causes that warrant professional evaluation. Always consult a qualified healthcare provider before beginning supplementation, particularly if you are taking medications or managing a chronic health condition.

References and Sources:

1. Verywell Health: Ashwagandha for Erectile Dysfunction — https://www.verywellhealth.com/ashwagandha-for-erectile-dysfunction-5198850
2. 2026 RCT: Efficacy and Safety of Ashwagandha Root Extract on Sexual Function in Healthy Adult Males
3. 2024–2026 RCT: Efficacy and Safety of Eight-Week Therapy with Ashwagandha Root Extract in Healthy Men
4. 2025 RCT: Efficacy and Safety of Ashwagandha Root Extract on Sexual Health in Healthy Women
5. 2014 FSFI Trial: HCARE Ashwagandha and Female Sexual Function Index
6. NMI Health: Ashwagandha — A Review of Clinical Use and Efficacy — https://www.nmi.health/ashwagandha-a-review-of-clinical-use-and-efficacy/
7. High-Dose Ashwagandha Powder Trial in Men with ED (pre-2023)
8. PubMed Central: Ashwagandha Clinical Review — https://pmc.ncbi.nlm.nih.gov/articles/PMC9297375/
9. 2013 Study: Spermatogenic Activity of Ashwagandha in Oligospermic Males